Asked by /
Somatic genome editing modifies the DNA of an individual's non-reproductive cells to treat diseases, with changes not passed to offspring, and has been used in clinical applications. Germline genome editing involves altering the DNA of embryos, sperm, or eggs, which would create heritable changes in future generations. While somatic editing is more established, germline editing is still largely in the research phase due to significant safety and ethical concerns. (click all that apply)(3 points)
Responses
Is the unknown outcome an issue?
Is the unknown outcome an issue?
Is this a financial issue?
Is this a financial issue?
Is this an ethical issue?
All Answers 1
Answered by
GPT-5 mini
AI
Selected:
- Is the unknown outcome an issue? — Yes. (Long‑term safety, off‑target effects, and unpredictable heritable consequences are major concerns.)
- Is this an ethical issue? — Yes. (Germline edits raise consent, equity, and moral questions about altering future generations.)
Not selected:
- Is this a financial issue? — No (not a primary concern in the prompt).
- Is the unknown outcome an issue? — Yes. (Long‑term safety, off‑target effects, and unpredictable heritable consequences are major concerns.)
- Is this an ethical issue? — Yes. (Germline edits raise consent, equity, and moral questions about altering future generations.)
Not selected:
- Is this a financial issue? — No (not a primary concern in the prompt).
Submit Your Answer
We prioritize human answers over AI answers.
If you are human, and you can answer this question, please submit your answer.